2013-17382. Sensient Technologies Corporation; Withdrawal of Color Additive Petition  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice of withdrawal.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing the withdrawal, without prejudice to a future filing, of a color additive petition (CAP 8C0261) proposing that the color additive regulations be amended to provide for the safe use of External D&C Violet No. 2 in coloring externally applied drug products.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ellen Anderson, Center for Food Safety and Applied Nutrition (HFS-265), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740-3835, 240-402-1309.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In a notice published in the Federal Register of August 24, 1998 (63 FR 45073), FDA announced that a color additive petition (CAP 8C0261) had been filed by Warner-Jenkinson Co., Inc. (now part of Sensient Cosmetic Technologies, a unit of Sensient Technologies Corporation), 107 Wade Ave., South Plainfield, NJ 07080. The petition proposed to amend the color additive regulations in 21 CFR part 74 Listing of Color Additives Subject to Certification to provide for the safe use of External D&C Violet No. 2 in coloring externally applied drug products. Sensient Technologies Corporation has now withdrawn the petition without prejudice to a future filing (21 CFR 71.6(c)(2)).

    Start Signature

    Dated: July 16, 2013.

    Dennis M. Keefe,

    Director, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition.

    End Signature End Supplemental Information

    [FR Doc. 2013-17382 Filed 7-18-13; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Published:
07/19/2013
Department:
Food and Drug Administration
Entry Type:
Proposed Rule
Action:
Notice of withdrawal.
Document Number:
2013-17382
Pages:
43093-43093 (1 pages)
Docket Numbers:
Docket No. FDA-1998-C-0381
PDF File:
2013-17382.pdf
CFR: (1)
21 CFR 74